Jiansheng Lin
Chunyan Lin2,3
Jingyang Zheng- 1Microbiology Laboratory, Quanzhou Women’s and Children’s Hospital, Quanzhou, China
- 2The Affiliated Women’s and Children’s Hospital of Huaqiao University, Quanzhou, China
- 3Respiratory Department, Quanzhou Women’s and Children’s Hospital, Quanzhou, China
Background: P. diazotrophicus was isolated from a newborn with D-galactosemia complicated sepsis. A homologous blaCAR-2 gene, encoding CAR-2, a predicted member of the CAR family subclass B3 metallo-β-lactamases (MBLs), was found in the genome of this strain. This study aimed to explore the identification of a novel CAR-2 protein encoded by the chromosome of P. diazotrophicus Pd1 that exhibits the zinc-binding motifs of subclass B3 enzymes and the regulatory pattern of CARR, located directly upstream of the blaCAR-2 gene, on the blaCAR-2 gene and its impact on antibiotic resistance.
Methods: Antibiotic susceptibility testing was conducted by the plate agar dilution method. Site-directed mutagenesis was conducted using Mut Express II Fast Mutagenesis Kit V2. Kinetic assays were used to determine the hydrolysis of β-Lactam. The construction of bacterial knockout strains was carried out according to the principle of homologous recombination. The detection of the mRNA expression level of the gene was performed by Real-time Quantitative PCR (qPCR).
Results: The minimum inhibitory concentrations (MICs) for E.coli DH5α(pHSG398::CAR-2), which expressed blaCAR-2, increased significantly for cefalothin, cefuroxime and cefotaxime sodium by 2-, 16- and 32- fold, respectively, which showed that blaCAR-2 had resistance to these three antibiotics. This protein, which was a MBL, contains two classical zinc-binding sites characteristic of subclass B3, with the amino acid motif His136, His138, His211, Asp140, His141, and His276. Among the six residues, His136, Asp140, and His211 exhibited the highest catalytic activity. We determined that CAR-2 can effectively hydrolyze cefalothin, cefuroxime and cefotaxime. The chloramphenicol resistance of the constructed E. coli DH5α strain was significantly reduced in the presence of CARR than in the absence of CARR. Compared with those for the wild-type P. diazotrophicus, MICs of cefalothin, cefuroxime and cefotaxime for the ΔCARR strain increased by 8-, 8- and 16-fold, respectively, and the expression level of blaCAR-2 also increased by approximately 10-fold.
Conclusion: Overall, CAR-2 is a novel subclass B3 MBL of the CAR family that exhibits catalytic activity against cefalothin, cefuroxime and cefotaxime. CARR represses the expression of blaCAR-2, thereby reducing the resistance of P. diazotrophicus to these antibiotics. This provided a theoretical basis for revealing new mechanisms of pathogen resistance.
Introduction
Phytobacter diazotrophicus (P. diazotrophicus) belongs to the Enterobacteriaceae family and was initially identified as a gram-negative bacterium that promotes plant growth. Subsequently, this species has been associated with opportunistic infections in humans and nosocomial settings (Pillonetto et al., 2018b; Kubota et al., 2023). The clinical significance of P. diazotrophicus has likely been underestimated due to frequent misidentification of clinical isolates as other Enterobacteriaceae (Pillonetto et al., 2018a). β-lactam antibiotics are the primary therapeutic agents for treating infections caused by P. diazotrophicus. In the past 2 years, clinical reports have described the emergence of multidrug-resistant P. diazotrophicus strains (Hon et al., 2023; Almuzara M et al., 2024). In 2010, The Lancet Infectious Disease published an article on the New Delhi metallo-β-lactamase-1 (NDM-1) superbug, which attracted widespread public and scientific attention (Kumarasamy et al., 2010). The increased global use of antibiotics has contributed to the rise of NDM-1-producing superbugs (Ranjan and Thatikonda, 2021). NDM-1-producing P. diazotrophicus strains have been detected in hospitalized patients and healthcare environments (Kubota et al., 2023). Currently, metallo-β-lactamase (MBL)-producing pathogens represent a major threat to clinical treatment options (S et al., 2023).
Clinically, Ambler classifies β-lactamases into four categories: A, B, C, and D (Ambler, 1980). Among them, the active sites of classes A, C, and D are serine residues; they are also known as serine-β-lactamases. In contrast, class B enzymes require metal ion coordination at the active site and are referred to as MBLs. Many novel MBLs have been speculated to originate from environmental bacteria, which serve as a large reservoir of antibiotic resistance genes that can be transferred into pathogenic bacteria (Martínez, 2018). MBLs can hydrolyze a broad spectrum of β-lactam antibiotics, except for monobactams, and their activity can be inhibited by metal ion-chelating agents such as EDTA, phenanthroline, and sulfhydryl compounds (Fisher et al., 2005). Class B MBLs are further divided into three subclasses, B1, B2, and B3, based on their amino acid sequences, structural features, and the number of zinc ion-binding sites (Krco et al., 2023). Subclass B3 is classified separately from B1 and B2 due to its extremely low sequence homology with the other subclasses. Most characterized subclass B3 MBLs have been discovered in environmental bacteria, but have been increasingly identified in clinical samples (Krco et al., 2023). The discovery of Adelaide Imipenemase (AIM-1), a subclass B3 MBL in Pseudomonas aeruginosa (P. aeruginosa) that efficiently hydrolyzes a wide range of β-lactam antibiotics and performs better than subclass B1 MBLs such as IMP-1 and VIM-2, suggests that the functional significance of subclass B3 MBLs has been underestimated (Yong et al., 2012). Given the increasing prevalence of antibiotic resistance, the absence of effective MBL inhibitors in clinical practice has become an urgent concern (Mojica et al., 2022).
We isolated and cultured gram-negative bacilli from the blood of a newborn with D-galactosemia complicated by sepsis. This strain was successfully identified as P. diazotrophicus, named P. diazotrophicus Pd1 (Lin et al., 2024). The genome of this strain carries gene_2795, a homolog of blaCAR. To facilitate its distinction from the previously reported blaCAR-1 gene (locus number: ECA2849) and its encoded protein CAR-1, our research group named the gene_2795 in P. diazotrophicus as blaCAR-2, and its encoded protein CAR-2. Previous literature reported that the CAR-1 protein, the CAR family, subclass B3 MBLs, can effectively hydrolyze broad-spectrum β-lactam antibiotics (Stoczko et al., 2008). In the genome of P. diazotrophicus Pd1, directly upstream of blaCAR-2 is gene_2796, which is divergently transcribed relative to blaCAR-2 gene and encodes a LysR-type transcriptional regulatory protein. This gene was named the CAR-related regulator (CARR). However, the mechanism of action of the CAR-2 protein and the CARR regulatory protein in emerging pathogenic bacteria, as well as the regulatory relationship between CARR and the blaCAR-2 gene, remain unclear.
Herein, we report the identification of a novel CAR-2 protein encoded by the chromosome of P. diazotrophicus Pd1 that exhibits the zinc-binding motifs of subclass.
B3 enzymes. By constructing active mutants of the CAR-2 protein, the active site of this protein was determined based on changes in antibiotic susceptibility testing. To clarify the function of the CAR-2 protein in hydrolyzing antibiotics, we conducted kinetic measurements. In this study, through gene knockout and expression analysis, we explored the regulatory pattern of CARR on the blaCAR-2 gene and its impact on antibiotic resistance.
Materials and methods
Bacterial strains and culture conditions
P. diazotrophicus Pd1, E. coli DH5α and E. coli BL21(DE3) were preserved in our laboratory. E. coli DH5α served as the host for constructing recombinant plasmids. E. coli BL21(DE3) was used for the induced expression of the CAR-2 protein. E. coli S17-1(λpir) was purchased from Beyotime Biotechnology and was used for constructing suicide plasmid. P. diazotrophicus Pd1 was cultured on a blood agar plate at 37°C. The draft complete sequences of P. diazotrophicus Pd1 was deposited in NCBI GenBank under the accession number: PRJNA1020661.
Sequence analysis for CAR-2
To clarify the similarity between predicted CAR-2 and other β-lactamases, we conducted the analysis through the Beta-lactamase database (BLDB)-structure and function BLAST analysis (http://www.bldb.eu:4567/). The signal peptide was predicted through protein signal peptide prediction (https://www.novopro.cn/tools/signalp). The molecular mass and predicted isoelectric point of CAR-2 were estimated using ExPASy(https://web.expasy.org/compute_pi/).
Expression of blaCAR-2 in E. coli DH5α
A pHSG398::CAR-2 construct was generated to test the β-lactam substrate specificity of CAR-2, as described previously (Ranjan et al., 2021). High-fidelity PCR was used to amplify the complete coding frame sequence of blaCAR-2 with the forward primer EcoRI-blaCAR-2-F and the reverse primer PstI-blaCAR-2-R. The primer design was carried out using Primer 5 software with the following parameter settings: annealing temperature is 58–62°C, primer length is 18–24 bp, and GC content is 40–60%. Primer sequences are shown in Supplementary Table S1. High-fidelity PCR was purchased from Vazyme. The total reaction volume of 50 µL consisted of 20 µL ddH2O, 25 µL 2× Phanta Max Master Mix, 2 µL primer F, 2 µL primer R, and 1 µL template DNA. The thermal cycle was programmed for 3 min at 95°C for pre-denaturation, followed by 32 cycles of 15 s at 95°C for denaturation, 15 s at 60°C for annealing, 60 s at 72°C for extension; a final extension was conducted for 5 min at 72°C. The PCR product and the pHSG398 plasmid (Takara) were double-digested with EcoRI and PstI, and then the PCR product was ligated to the pHSG398 plasmid using T4 ligase. The restriction enzymes EcoRI and PstI were purchased from Thermo Fisher Scientific. Using the forward primer EcoRI-blaCAR-2-F and the reverse primer PstI-blaCAR-2-R, PCR was performed to verify that the recombinant pHSG398 plasmid was successfully connected and transformed into E. coli DH5α, which was named E.coli DH5α(pHSG398::CAR-2). This recombinant strain expresses blaCAR-2 under the control of the lac promoter. Similarly, using the forward primer Test-pHSG398-F and the rear primer Test-pHSG398-R, PCR was performed to confirm the successful transformation of the empty pHSG398 plasmid into E. coli DH5α, which was named E.coli DH5α(pHSG398). This strain was used as a negative control.
Antibiotic susceptibility testing
The minimum inhibitory concentration (MIC) values of susceptibility of strains to 14 kinds of β-lactam antibiotics including ampicillin, piperacillin, carbenicillin, cefalotin, cefoxitin, cefuroxime, ceftazidime, cefotaxime, ceftazidime/clavulanic acid, cefepime, aztreonam, imipenem, meropenem, and ertapenem were detected by the Mueller-Hinton (MH) agar plate dilution method. Antibiotics were purchased from Aladdin Biochemical Technology Co., Ltd. In brief, we first revived strains on a blood plate for 24 hours, then picked single clones and subcultured them for 24 hours. Subsequently we added each antibiotic with a serial dilution concentration to an empty plate, and then poured 25 mL of MH agar medium at about 50°C into each plate. Next, we adjusted the bacterial suspension concentration to 0.5 McFarland turbidity standard with a McFarland turbidimeter, and titrated 1 μL of the bacterial suspension onto the surface of the MH agarplates. After air-drying, finally we placed the plates in an incubator at 37°C, and observed the MIC values of each strain 20 hours later. E. coli ATCC8739 was selected as the quality control bacterium. Repeat the biological experiment three times.
For determination of blaCAR-2 MBL activity, MIC values of 14 kinds of β-lactam antibiotics were also determined in the presence of 0.2 mM EDTA to demonstrate the reduction in the blaCAR-2 activity due to metal chelation.
Construction of mutations at the key active sites of the CAR-2 protein
To test the key active sites of the CAR-2 protein, we constructed six single mutants (H136A, H138A, H211A, D140A, H141A, and H276A) in E. coli DH5α. Site-directed mutagenesis was conducted using Mut Express II Fast Mutagenesis Kit V2 (Vazyme Biotech Co., Ltd). Briefly, the codons corresponding to the amino acid residues His136, His138, His211, Asp140, His141, and His276 were replaced with the codon GCC, corresponding to alanine(A), at the 5’ end of the primers. Primer sequences are listed in Supplementary Table S1. Using pHSG398::CAR-2 plasmid DNA as a template, six single mutant plasmids—pHSG398::CAR-2(H136A), pHSG398::CAR-2(H138A), pHSG398::CAR-2(H211A), pHSG398::CAR-2(D140A), pHSG398::CAR-2(H141A), and pHSG398::CAR-2(H276A)—were amplified with the primer pairs mentioned above. Subsequently, these plasmids were individually transformed into E. coli DH5α. Sanger sequencing (first-generation sequencing) using the forward primer Sanger-F and the rear primer Sanger-R was performed to determine the ~650 bp region containing the mutation site. Sequence alignment using the Chromas software confirmed the successful construction of all six single mutant strains.
Induced expression and purification of recombinant CAR-2 protein
Firstly, we used high-fidelity PCR to amplify the coding frame sequence (removing the signal peptide sequence) of blaCAR-2 with the forward primer NdeI-CAR-2-F and the reverse primer XhoI-CAR-2-R. The restriction enzymes NdeI and XhoI were purchased from Thermo Fisher Scientific. Primer sequences was showed in Supplementary Table S1. The PCR product and pET-21b(+) were double-digested with NdeI and XhoI, and then PCR product ligated to the pET-21b(+) plasmid using T4 ligase. Using the forward primer NdeI-CAR-2-F and the reverse primer XhoI-CAR-2-R, PCR was performed to verify that the Recombinant pET-21b(+) plasmid was successfully transformed into E. coli BL21(DE3), which was named E. coli BL21(DE3) (pET-21b-CAR-2). A single clone of E. coli BL21(DE3) (pET-21b-CAR-2) was added to 500 mL of liquid LB medium and cultured at 37°C and 220 rpm/min for 9 hours. Subsequently, we added IPTG to the bacterial culture to a final concentration of 0.5 mM and then incubated it on a shaker overnight at 37°C.The bacterial culture was collected by centrifugation at 5000rpm/min for 5 minutes and resuspended in a Tris·HCl buffer solution containing 20 mM imidazole. The bacteria were lysed by sonication (power 30%, sonication time 45 min, on for 3 s and off for 3 s).After centrifuging the lysate at 12,000 rpm/min for 20 minutes, it was filtered through a sterilizing filter. In the affinity chromatography column, the filtrate was mixed with Ni2+-NTA Agarose 6FF (Shanghai Yuanye Bio - Technology Co., Ltd) for 30 minutes. A Tris·HCl buffer solution containing 20 mM imidazole was used as the washing buffer to elute the non-target proteins. A Tris·HCl buffer solution containing 50 mM, 100 mM, 200 mM, 300 mM or 400 mM imidazole was used as the elution buffer to elute the target protein bound to the nickel column. The purification effect was analyzed by SDS-PAGE. The His-tagged CAR-2 protein was dialyzed overnight in a PBS buffer solution (pH 7.4) using a dialysis bag. The concentration of the recombinant CAR-2 protein was determined by a Nano-300 Micro-Spectrophotometer.
Determination of kinetic parameters
Kinetic assays were conducted with a UV-1100 spectrophotometer as previously described (Stoczko et al., 2008).β-Lactam hydrolysis was detected by monitoring the variation in absorbance using the characteristic molecular extinction coefficient to substrates: cefalothin (Δϵ260nm=-14,300 M-1cm-1); cefuroxime (Δϵ274nm=-18,600 M-1cm-1); cefotaxime sodium (Δϵ264nm=-11,625 M-1cm-1). The assays were conducted at 25°C with 3 ml of reaction mixture in 50mM HEPES buffer, pH 7.5 containing CAR-2 protein (0.634µM for cefalothin;1.27µM for cefuroxime; 0.634µM for cefotaxime sodium), 50µM ZnSO4.The steady-state kinetic parameters (vmax and km) were calculated after direct fit of the Michaelis-Menten equation on the experimental data with the program GraphPad. The value of kcat was obtained by dividing vmax by the CAR-2 protein concentration.
Construction of E.coli DH5α (pBluescript/IR111-CmR) and E.coli DH5α (pBluescript/CARR-IR111-CmR) for MIC experiments
To demonstrate that CARR binds IR111 (the 111- bp sequence of the interval between CARR and blaCAR-2) and inhibits the expression of the chloramphenicol resistance gene CmR, we constructed E.coli DH5α (pBluescript/IR111-CmR) and E.coli DH5α (pBluescript/CARR-IR111-CmR). In brief, the IR111 fragment and IR111-CARR fragment were amplified from P. diazotrophicus Pd1 genomic DNA using primers IR111-F, IR111-R and IR111-F, IR111-CARR-R, respectively. The CmR coding frame sequence was amplified from the pDM4 plasmid using primers CmR-F and CmR-R. IR111 and CmR were ligated to pBluescript double-digested with KpnI and SacII by ligase independent cloning (LIC) with ClonExpress MultiS One Step Cloning Kit (Vazyme Biotech Co., Ltd).Likewise, IR111-CARR and CmR were ligated into the pBluescript vector. The two recombinant plasmids were subsequently introduced into E.coli DH5α by heat shock. Finally, the MIC values of chloramphenicol in E. coli DH5α (pBluescript/IR111-CmR) and E. coli DH5α (pBluescript/CARR-IR111-CmR) were determined by the plate agar dilution method.
Construction of the CARR deletion mutant strain(ΔCARR)
The construction of ΔCARR was carried out according to homologous recombination. In brief, a upstream 583 bp fragment and a downstream 635 bp fragment of CARR were amplified from P. diazotrophicus Pd1 genomic DNA with primers CARR-up-F, CARR-up-R, and primers CARR-down-F, CARR-down-R, respectively. These two fragments and a tetracycline resistance cassette, which was amplified with CARR-TC-F and CARR-TC-R, were ligated into Suicide pDM4 plasmid by LIC with ClonExpress MultiS One Step Cloning Kit. The recombinant plasmids were subsequently introduced into P. diazotrophicus Pd1 strains by electrotransformation. The bacterial solution was subsequently spread on LB agar plates containing tetracycline (20µg/mL) and piperacillin (24µg/mL). A single colony was subcultured for 5 generations in liquid LB medium. Then, 20µl of bacterial culture was spread on LB agar plates containing tetracycline (20µg/mL). Chromosomal DNA of the transformants was checked by PCR with primers CARR-Delete-F and CARR-Delete-R. The primers used in this study are listed in Supplementary Table S1.
RNA isolation and quantitative PCR
RNA extraction was performed using the FreeZol Reagent (Vazyme Biotech Co., Ltd) according to the Manufacturer’ instructions. The RNA concentration was analyzed using a Nano-300Micro-Spectrophotometer. Subsequently, 500 ng of total RNA was reverse transcribed into cDNA with the HiScript III RT SuperMix for qPCR(+gDNA wiper) kit (Vazyme Biotech Co., Ltd). Real time quantitative PCR (qPCR) was performed using a fully-automated real-time fluorescent quantitative PCR analysis system Gentier 96 (Tianlong Technology Co., Ltd, Xi’an, China) with ChamQ Blue Universal SYBR qPCR Master Mix (Vazyme Biotech Co., Ltd) in 50 ng of cDNA. The primers used are detailed in Supplementary Table S1. Data normalization was performed using 16S rRNA (a housekeeping gene), and relative gene expression was calculated using the 2–ΔΔCt approach.
Statistical analysis
Student’s t-tests was used to evaluate the statistical significance of differences. A P-value < 0.05 was considered to indicate a statistically significant difference.
Results
Sequence features of CAR-2
The 990-bp blaCAR-2 encodes a 330-residue protein, which the highest sequence identity (60.82%) with subclass B3 MBLs CAR-1, as shown in Figure 1. Compared with that in CAR-1, the N-terminus of CAR-2 lacks a segment of 10 residues, LPSQGTETKG. CAR-2 shows lower identity to other subclass B3 MBLs, with identity scores ranging from 27.99% (AIM-1) to 34.85% (BJP-1). The novel CAR-2 was predicted to have two zinc-binding motifs: His136, His138, His211, Asp140,His141, and His276, as shown in Figure 1. The estimated theoretical isoelectric point and molecular weight of CAR-2 without the predicted signal peptide were 7.28 and 33.717 kDa, respectively. CAR-2 is speculated to possess three external loops (eLs), namely eL1- eL3 (Stoczko et al., 2008; Yun et al., 2022), as shown in Figure 1.
Figure 1. Sequence alignment analysis of the amino acid sequences between CAR-2 and CAR-1 note: Score 433.72, E value 5.36×10-154, Identities 208/342 (60.82),Gaps 12/342 (3.51),Positives 256/342 (74.85).The square represents the zinc-binding sites. The signal peptide was marked with a black underline. External loops (eLs) were marked with a red underline. The light blue underlining indicated the position of Thr57Ile as reported in the literature (Lin et al., 2024).
Characterization of the MBL CAR-2
To clarify the substrate specificity of CAR-2, we constructed E.coli DH5α(pHSG398::CAR-2), which expressed CAR-2, and tested the MIC values for 14 β-lactam antibiotics. Compared with those for E.coli DH5α and E. coli DH5α(pHSG398), the MIC values for E.coli DH5α(pHSG398::CAR-2) increased significantly only for cefalothin, cefuroxime and cefotaxime sodium by 2-, 16- and 32- fold, respectively (Table 1). This result indicates that cefalothin, cefuroxime and cefotaxime are substrates of CAR-2. To confirm that CAR-2 is a MBL, we measured MICs in the presence of EDTA. Compared with those for E. coli DH5α(pHSG398::CAR-2) without EDTA, the MIC values for cefalothin, cefuroxime and ceftriaxone sodium in the presence of EDTA dropped to baseline levels (Table 1). This confirms that EDTA inhibited CAR-2 catalytic activity, indicating that CAR-2 is a MBL.
Table 1. The MIC values of antibiotics for different transformants of E. coli DH5α.
To determine the catalytic active site of CAR-2, we constructed six single mutants: E.coli DH5α[pHSG398::CAR-2(H136A)], E.coli DH5α[pHSG398::CAR-2(H138A)], E. coli DH5α [pHSG398::CAR-2(H211A)], E. coli DH5α [pHSG398::CAR-2(D140A)], E. coli DH5α[pHSG398::CAR-2(H141A)], and E. coli DH5α[pHSG398::CAR-2(H276A)], as shown in Supplementary Figure S1. Subsequently, we tested the MICs for cefuroxime and cefotaxime sodium. Cefuroxime susceptibility results revealed that compared with E. coli DH5α(pHSG398::CAR-2), mutants H136A, D140A and H211A showed the greatest MIC reduction- dropping the baseline levels, H138A and H276A showed moderate decreases, and H141A the least (Table 2). Cefotaxime MICs mirrored this trend. We conclude that these six residues are active sites, with H136, D140, and H211 being the primary zinc-binding sites.
Table 2. The MIC values of antibiotics for various mutants of CAR-2 on the pHSG398 plasmid in E. coli DH5α.
CAR-2 hydrolyzed cefalothin, cefuroxime and cefotaxime
We successfully induced the recombinant CAR-2 protein, and the size of this protein is consistent with the expected molecular weight of approximately 35 kDa, as shown in Supplementary Figure S2. To demonstrate that CAR-2 acted as a MBL can hydrolyze cefalothin, cefuroxime and cefotaxime, we performed CAR-2 enzymatic kinetic experiments. kcat was 0.84S-1 and kcat/km was 1.32×104 M-1·S-1 for cefalothin; kcat was 0.21 S-1 and kcat/km was 4.26×103 M-1·S-1 for cefuroxime; and kcat was 0.61 S-1, kcat/km was 1.87×104 M-1·S-1 for cefotaxime sodium, as shown in Table 3. When 1 mM of EDTA was added to the above reaction solution, no activity was observed, indicating that the CAR-2 enzyme requires zinc ions.
Table 3. Kinetic parameters of CAR-2.
CARR inhibited the expression of blaCAR-2
Through alignment analysis using DNAMAN software, the amino acid sequence of this CARR showed 63.76% similarity to that of the LysR-type transcriptional regulator (ECA2848)) located directly upstream of CAR-1. However, the CARR protein was poorly conserved with β-lactamase transcriptional regulators such as AmpR, VarR, and NmcR. The antibiotic sensitivity results showed that the MIC values of chloramphenicol for E.coli DH5α(pBluescript/IR111-CmR) and E.coli DH5α(pBluescript/CARR-IR111-CmR) were 120 µg/mL and 30 µg/mL, respectively, as shown in Figure 2. In the presence of CARR, the MIC of chloramphenicol decreased 4-fold (P < 0.001). These results indicate that CARR likely inhibits blaCAR-2 expression through the IR111 promoter. We successfully constructed the CARR deletion mutant strain, as shown in Supplementary Figure S3. To further prove that CARR inhibits the expression of blaCAR-2, we used qPCR to detect the mRNA expression of 16S rRNA and blaCAR-2 in P. diazotrophicus Pd1 wild-type strain andΔCARR, as shown in Supplementary Figure S4. Compared with that of the wild-type strain, the mRNA expression of blaCAR-2 in the ΔCARR strain increased approximately 10-fold (P < 0.01), as shown in Figure 3, indicating that CARR inhibited blaCAR-2 expression.
Figure 2. MIC values of E.coli DH5α (pBluescript/IR111-CmR) and E.coli DH5α (pBluescript/CARR-IR111-CmR) for chloramphenicol (*** denotes P < 0.001).
Figure 3. Determination of mRNA expression of blaCAR-2 in P. diazotrophicus Pd1 wild-type strain and ΔCARR (** denotes P < 0.01).
CARR reduced resistance to cefalothin, cefuroxime and cefotaxime
In order to clarify the association between CARR and cefalothin, cefuroxime and cefotaxime sodium, the MIC values of cefalothin, cefuroxime and cefotaxime sodium of P. diazotrophicus wild-type strain and ΔCARR strain were determined. Compared with those of the wild-type strain, the MIC values of the ΔCARR strain for cefalothin, cefuroxime and cefotaxime sodium increased 8-,8- and 16-fold, respectively, as shown in Table 4. These results demonstrated that CARR reduced the resistance to cefalothin, cefuroxime and cefotaxime sodium. Therefore, we conclude that CARR inhibits the expression of blaCAR-2, which reduces the resistance of P. diazotrophicus to cefalothin, cefuroxime and cefotaxime.
Table 4. Analysis of the impact of knocking out CARR on the MIC values of cefalothin, cefuroxime and cefotaxime in P. diazotrophicus.
Discussion
Subclass B1 prefers penicillin and cephalosporins as substrates, subclass B2 prefers carbapenems as substrates, and subclass B3 prefers penicillin as a substrate (Bush and Jacoby, 2010). The best substrates for CAR-1 were cephalothin, cefuroxime, and cefotaxime (Stoczko et al., 2008). The substrates for CAR-2 were also cephalothin, cefuroxime and cefotaxime. The CAR family MBLs prefer a small number of cephalosporins as substrates. AIM-1, as another member of subclass B3 MBLs, efficiently catalyzes carbapenemases. Therefore, evidently, the substrates of subclass B3 MBLs are quite different.
Subclasses B1 and B3 bind to two zinc ions, whereas subclass B2 binds to a single zinc ion (Bebrone, 2007). For subclasses B1 and B3, the first zinc ion coordinates and binds with the residues His116, His118, and His121; the second zinc ion coordinates and binds with the residues Asp120, Cys221, and His263 for subclass B1. For subclass B3, the second zinc ion coordinates and binds with the residues Asp120, His121, and His263 (Bebrone, 2007; Somboro et al., 2018). However, unlike that in subclasses B1 and B2, considerable diversity exists within the active site motif of subclass B3, such as the non-classical binding sites H116Q and H116E in the first zinc ion and a new combination (H118R, H121Q, and H263K) in the second zinc ion (Berglund et al., 2021). Different from the direct enzymatic activity analysis of protein point mutations (Lee et al., 2019), we directly used the constructed point mutation strains to judge the enzymatic activity by observing drug sensitivity changes, which omitted the protein inducible expression process. Unlike the active-site mutants of PNGM-1 (a subclass B3 MBL), which completely lack catalytic activity (Lee et al., 2019), the H138A and H141A mutants of the CAR-2 protein exhibit partial activity, indicating the uniqueness of the working mode of the active site in the CAR-2 protein. This study determined that CAR-2 has two classical zinc-binding motifs, His136, His138, His211, Asp140, His141, and His276.
The monometallic (zinc) form of subclass B2 MBLs exhibits a high degree of specificity for carbapenem antibiotics (Garau et al., 2005; Fonseca et al., 2011). Similar to AIM-1, GOB-1 belonging to subclass B3 MBLs is also effective against a broad range of β-lactam antibiotics, in particular carbapenems. Thus, it is possible that GOB-1 MBL is active in both mono- and bi-metallic form states (Morán-Barrio et al., 2007; Lisa et al., 2010), which contributes that the substrate spectrum of GOB-1 covers a broad range of β-lactam antibiotics. Based on the fact that the antibiotic susceptibility profiles of CAR-1 and CAR-2 showed no significant correlation with carbapenem resistance, we inferred that CAR family subclass B3 MBLs occurred in bi-metallic form state, which could contribute that the substrates of CAR family subclass B3 MBLs primarily cover cephalosporin antibiotics.
The substrate-binding pocket differs among the three subclasses and is especially important for substrate specificity and drug resistance (Yun et al., 2022). In the superimposed crystal structures of MBLs, there were conserved secondary structures of 5 α-helices and 13 β-strands as the core scaffold. The four loops of L1–4 coordinate the catalytic zinc ion(s), and the three eL1–3 formed a substrate-binding pocket. According to the report of CAR-1, the substitution of the conserved site from Thr57 to Ile in subclass B3 MBLs was considered not to affect the function (Stoczko et al., 2008). However, we believed that the substitution at this site was highly likely to affect the substrate specificity of proteins in the CAR family, because this site was located in the eL1 regions of both CAR-1 and CAR-2, as shown in Figure 1.The long N-terminal tail forming eL1 showed varied relative positions in the different B3 MBL structures of L1, GOB-1, CSR-1, and AIM-1,which could affect the catalytic activity (Pedroso et al., 2020). Compared with the high catalytic activities of CAR-1 to cefalothin, cefuroxime and cefotaxime (with Kcat/Km values of 1.2×106 M-1·S-1, 3.6×106 M-1·S-1 and 1.5×106 M-1·S-1 respectively), the catalytic activity of CAR-2 is significantly decreased. There are two reasons for this difference: firstly, the signal peptide of the recombinant CAR-2 has been removed; secondly, CAR-2 lacks 10 amino acid residues at the N-terminus, which both affected the formation of the N-terminal loop at the N-terminus and the catalytic activity. Importantly, the amino acid residues of the eL2 loop in CAR-2 differed significantly from those in CAR-1, as shown in Figure 1, which may have affected the substrate specificity of CAR-2.
The fifth gene, upstream of blaCAR-2 gene, encodes an IS3 family transposase, IS Ehe3, which can promote the horizontal movement of blaCAR-2 between the genomes of different bacteria. This result was consistent with previous findings stating that blaCAR-1 can be horizontally transmitted between bacteria via a horizontally acquired genomic island (HAI12) (Stoczko et al., 2008). NCBI database analysis revealed that the coexistence of blaCAR-2 and CARR was found only in certain strains of P. diazotrophicus and Phytobacter ursingii (P. ursingii) within the genus Phytobacter. However, the coexistence pattern of the homologues of blaCAR-2 and CARR is common in the genus Pectobacterium. Therefore, the coexistence of blaCAR-2 and CARR in the genus Phytobacter could have evolved from Pectobacterium. According to the reports in the literature on the method of gene knockout in P. diazotrophicus (Wang et al., 2019), we successfully constructed the CARR gene knockout strain. This study is the first to explore the role of the CARR gene in drug resistance mechanisms. This study further confirmed that the expression of blaCAR-2 was inhibited by CARR in P. diazotrophicus. The limitation of this study lies in the failure to further clarify whether the homologues of CARR can inhibit the expression of the homologues of blaCAR-2 in the strains mentioned above. The metabolic trade-off theory is an important concept in the fields of ecology, evolutionary biology (Miller and O’Dwyer, 2024; Wang et al., 2024). Its core idea is that the energy and resources of organisms are limited. When these resources are allocated to one life activity (such as growth, reproduction, defense, etc.), the investment in other life activities will inevitably be reduced, thereby forming a “trade-off relationship” where one increases and the other decreases. CARR may repress antibiotic resistance to prioritize nitrogen fixation in P. diazotrophicus. This aligns with metabolic trade-off theory, where resistance genes impose fitness costs (Rajer and Sandegren, 2022).
AmpC synthesis is activated in the presence of β-lactam antibiotics as a result of AmpR derepression. This mechanism involves disruption of the peptidoglycan by β-lactams that leads to increased periplasmic accumulation of cell wall precursors and degradation products (muropeptides). Within the cytoplasm, muropeptides derepress AmpR leading to induction of AmpC (Dietz et al., 1997; Jacobs et al., 1997). The inhibition of the metallo-β-lactamase VarG by the LysR type transcription factor VarR can be relieved in the presence of penicillin G (Lin et al., 2017). However, in the presence of piperacillin (0.25µg/mL) or ampicillin (6µg/mL), the MIC values of chloramphenicol for E. coli DH5α (pBluescript/IR111-CmR) and E.coli DH5α (pBluescript/CARR-IR111-CmR) remained unchanged compared with those in the absence of β- lactam antibiotics. This indicates that muropeptides cannot induce the expression of blaCAR-2 by inhibiting CARR. In comparison to AmpR/AmpC, penicillin antibiotics fail to relieve CARR-mediated repression of blaCAR-2.The inducible expression of blaCAR-2 requires further in-depth research.
Conclusion
CAR-2 is a novel CAR family MBL that exhibits catalytic activity against cephalothin, cfuroxime and cefotaxime, and is strongly inhibited by EDTA. These six residues His136, His138, His211, Asp140, His141, and His276 are active sites, with His136, Asp140, and His211 being the primary zinc-binding sites. The inhibition of blaCAR-2 expression by CARR may act directly through the blaCAR-2 promoter, which reduces the resistance of P. diazotrophicus to cephalothin, cefuroxime and cefotaxime. This provided a theoretical basis for revealing new mechanisms of pathogen resistance.
Data availability statement
The draft complete sequences of P. diazotrophicus Pd1 was deposited in NCBI GenBank under the accession number: PRJNA1020661.
Ethics statement
The manuscript presents research on bacteria that do not require ethical approval for their study.
Author contributions
JL: Methodology, Writing – original draft, Conceptualization, Funding acquisition. CL: Writing – review & editing, Data curation. JZ: Writing – review & editing.
Funding
The author(s) declare financial support was received for the research and/or publication of this article. This research was funded by Quanzhou Science and Technology Project (no: 2023N046S) and Joint Funds for the Innovation of Science and Technology, Fujian Province (no: 2024Y9466).
Acknowledgments
We express our gratitude for the assistance provided by Professor Yang Huiyong’s team.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2025.1616646/full#supplementary-material
References
Almuzara M, C. R., Traglia, G., Haim, M. S., De Belder, D., Alvarez, C., de Lourdes Reynal, O., et al. (2024). Phytobacter spp: the emergence of a new genus of healthcare-associated Enterobacterales encoding carbapenemases in Argentina: a case series. Infect. Prev. Pract. 6, 100379. doi: 10.1016/j.infpip.2024.100379
Ambler, R. P. (1980). The structure of beta-lactamases. Philos. Trans. R Soc. Lond B Biol. Sci. 289, 321–331. doi: 10.1098/rstb.1980.0049
Bebrone, C. (2007). Metallo-b-lactamases(classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol. 74, 1686–1701. doi: 10.1016/j.bcp.2007.05.021
Berglund, F., Johnning, A., Larsson, D. G. J., and Kristiansson, E. (2021). An updated phylogeny of the metallo-β-lactamases. J. Antimicrob. Chemother. 76, 117–123. doi: 10.1093/jac/dkaa392
Bush, K. and Jacoby, G. A. (2010). Updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 54, 969–976. doi: 10.1128/AAC.01009-09
Dietz, H., Pfeifle, D., and Wiedemann, B. (1997). The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob. Agents Chemother. 41, 2113–2120. doi: 10.1128/AAC.41.10.2113
Fisher, J. F., Meroueh, S. O., and Mobashery, S. (2005). Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. Chem. Rev. 105, 395–424. doi: 10.1021/cr030102i
Fonseca, F., Bromley, E. H., Saavedra, M. J., Correia, A., and Spencer, J. (2011). Crystal structure of Serratia fonticola sfh-I: a ctivation of the nucleophile in mono-zinc metallo β-lactamases. J. Mol. Biol. 411, 951–959. doi: 10.1016/j.jmb.2011.06.043
Garau, G., Bebrone, C., Anne, C., Galleni, M., Frère, J. M., and Dideberg, O. (2005). A metallo-beta-lactamase enzyme in action: Crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. J. Mol. Biol. 345, 785–795. doi: 10.1016/j.jmb.2004.10.070
Hon, P., Ko, K. K. K., Zhong, J. C. W., De, P. P., Smits, T. H. M., Low, J., et al. (2023). Genomic identification of two phytobacter diazotrophicusIsolates from a neonatal intensive care unit in Singapore. Microbiol. Resour Announc 12, e001672. doi: 10.1128/mra.00167-23
Jacobs, C., Frère, J. M., and Normark, S. (1997). Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria. Cell 88, 823–832. doi: 10.1016/S0092-8674(00)81928-5
Krco, S., Davis, S. J., Joshi, P., Wilson, L. A., Monteiro Pedroso, M., Douw, A., et al. (2023). Structure, function, and evolution of metallo-β-lactamases from the B3 subgroup-emerging targets to combat antibiotic resistance. FrontChem 11, 1196073. doi: 10.3389/fchem.2023.1196073
Kubota, H., Nakayama, T., Ariyoshi, T., Uehara, S., Uchitani, Y., Tsuchida, S., et al. (2023). Emergence of Phytobacter diazotrophicus carrying an IncA/C(2) plasmid harboring blaNDM-1 in Tokyo, Japan. MSphere 8, e0014723. doi: 10.1128/msphere.00147-23
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., et al. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597–602. doi: 10.1016/S1473-3099(10)70143-2
Lee, J. H., Takahashi, M., Jeon, J. H., Kang, L. W., Seki, M., Park, K. S., et al. (2019). Dual activity of PNGM-1 pinpoints the evolutionary origin of subclass B3 metallo-β-lactamases: a molecular and evolutionary study. Emerg. Microbes Infect. 8, 1688–1700. doi: 10.1080/22221751.2019.1692638
Lin, H. V., Massam-Wu, T., Lin, C. P., Wang, Y. A., Shen, Y. C., Lu, W. J., et al. (2017). The Vibrio cholerae var regulon encodes a metallo-β-lactamase and an antibiotic efflux pump, which are regulated by VarR, a LysR-type transcription factor. . PloS One 12, e0184255. doi: 10.1371/journal.pone.0184255
Lin, J., Wu, J., Gong, L., Li, X., and Wang, G. (2024). Sepsis caused by Phytobacter diazotrophicus complicated with galactosemia type 1 in China: a case report. BMC Infect. Dis. 24, 599. doi: 10.1186/s12879-024-09458-y
Lisa, M. N., Hemmingsen, L., and Vila, A. J. (2010). Catalytic role of the metal ion in the metallo-beta-lactamase GOB. J. Biol. Chem. 285, 4570–4577. doi: 10.1074/jbc.M109.063743
Martínez, J. L. (2018). Ecology and evolution of chromosomal gene transfer be tween environmental microorganisms and pathogens. Microbiol. Spectr. 6, 10.1128. doi: 10.1128/microbiolspec.mtbp-0006-2016
Miller, Z. R. and O’Dwyer, J. P. (2024). Metabolic trade-offs can reverse the resource-diversity relationship. Am. Nat. 204, E85–E98. doi: 10.1086/732110
Mojica, M. F., Rossi, M. A., Vila, A. J., and Bonomo, R. A. (2022). The urgent need for metallo-β-lactamase inhibitors: An unattended global threat. Lancet Infect. Dis. 22, e28–e34. doi: 10.1016/S1473-3099(20)30868-9
Morán-Barrio, J., González, J. M., Lisa, M. N., Costello, A. L., Peraro, M. D., Carloni, P., et al. (2007). The metallo-beta-lactamase GOB is a mono-Zn(II) enzyme with a novel active site. J. Biol. Chem. 282, 18286–18293. doi: 10.1074/jbc.M700467200
Pedroso, M. M., Waite, D. W., Melse, O., Wilson, L., Mitić, N., McGeary, R. P., et al. (2020). Broad spectrum antibiotic-degrading metallo-beta-lactamases are phylogenetically diverse. Protein Cell 11, 613–617. doi: 10.1007/s13238-020-00736-4
Pillonetto, M., Arend, L. N., Faoro, H., D’Espindula, H. R. S., Blom, J., Smits, T. H. M., et al. (2018a). Emended description of the genus Phytobacter, its type species Phytobacter diazotrophicus (Zhang 2008) and description of Phytobacter ursingii sp. nov. Int. J. Syst. Evol. Microbiol. 68, 176–184. doi: 10.1099/ijsem.0.002477
Pillonetto, M., Arend, L., Gomes, S. M. T., Oliveira, M. A. A., Timm, L. N., Martins, A. F., et al. (2018b). Molecular investigation of isolates from a multistate polymicrobial outbreak associated with contaminated total parenteral nutrition in Brazil. BMC Infect. Dis. 18, 397. doi: 10.1186/s12879-018-3287-2
Rajer, F. and Sandegren, L. (2022). The role of antibiotic resistance genes in the fitness cost of multiresistance plasmids. mBio 13, e0355221. doi: 10.1128/mbio.03552-21
Ranjan, V. K., Mukherjee, S., Thakur, S., Gupta, K., and Chakraborty, R. (2021). Pandrug-resistant Pseudomonas spp. expresses New Delhi Metallo-β-lactamase-1 and consumes ampicillin as sole carbon source. Clin. Microbiol. Infect. 27, 472.e1–472.e5. doi: 10.1016/j.cmi.2020.10.032
Ranjan, R. and Thatikonda, S. (2021). β-lactam resistance gene NDM-1 in the aquatic environment: A review. Curr. Microbiol. 78, 3634–3643. doi: 10.1007/s00284-021-02630-6
Somboro, A. M., Osei Sekyere, J., Amoako, D. G., Essack, S. Y., and Bester, L. A. (2018). Diversity and proliferation of metallo-β-lactamases: a clarion call for clinically effective metallo-β-lactamase inhibitors. Appl. Environ. Microbiol. 84, e00698–e00618. doi: 10.1128/AEM.00698-18
S, S., N, H., Fasim, A., More, SS, and Das Mitra, S. (2023). Identification of a potential inhibitor for New Delhi metallo-β-lactamase 1 (NDM-1) from FDA approved chemical library- a drug repurposing approach to combat carbapenem resistance. J. Biomol Struct. Dyn. 41, 7700–7711. doi: 10.1080/07391102.2022.2123402
Stoczko, M., Frère, J. M., Rossolini, G. M., and Docquier, J. D. (2008). Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora. Antimicrob. Agents Chemother. 52, 2473–2479. doi: 10.1128/AAC.01062-07
Wang, M., Chen, X., Fang, Y., Zheng, X., Huang, T., Nie, Y., et al. (2024). The trade-off between individual metabolic specialization and versatility determines the metabolic efficiency of microbial communities. Cell Syst. 15, 63–74.e5. doi: 10.1016/j.cels.2023.12.004
Wang, B., Huang, B., Chen, J., Li, W., Yang, L., Yao, L., et al. (2019). Whole-genome analysis of the colonization-resistant bacterium Phytobacter sp. SCO41T isolated from Bacillus nematocida B16-fed adult Caenorhabditis elegans. Mol. Biol. Rep. 46, 1563–1575. doi: 10.1007/s11033-018-04574-w
Yong, D., Toleman, M. A., Bell, J., Ritchie, B., Pratt, R., Ryley, H., et al. (2012). Genetic and biochemical characterization of an acquired subgroup B3 metallo-beta-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob. Agents Chemother. 56, 6154–6159. doi: 10.1128/AAC.05654-11
Keywords: P. diazotrophicus, LysR-type transcriptional regulator CARR, metallo-β-lactamases (MBLs), blaCAR-2, antibiotic resistance
Citation: Lin J, Lin C and Zheng J (2025) LysR-type transcriptional regulator CARR represses the expression of blaCAR-2 and reduces P. diazotrophicus resistance to cefalothin, cefuroxime and cefotaxime. Front. Cell. Infect. Microbiol. 15:1616646. doi: 10.3389/fcimb.2025.1616646
Received: 23 April 2025; Accepted: 11 August 2025;
Published: 01 September 2025.
Edited by:
Michael Marceau, Université Lille Nord de France, FranceReviewed by:
Emily Stevens, Keele University, United KingdomMohamed Mohamed Adel El-Sokkary, Mansoura University, Egypt
Copyright © 2025 Lin, Lin and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiansheng Lin, NjM2Nzg0NjJAcXEuY29t; Jingyang Zheng, Mjc5Mjc3NDgxQHFxLmNvbQ==